An Inducible Caspase 9 Suicide Gene to Improve the Safety of Mesenchymal Stromal Cell Therapies
- 28 April 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 28 (6) , 1107-1115
- https://doi.org/10.1002/stem.433
Abstract
Mesenchymal stromal cells (MSCs) have been infused in hundreds of patients to date, with minimal reported side effects. However, follow-up is limitedKeywords
Funding Information
- Specialized Centers for Cell-Based Therapy Grant NIH-NHLBI (1 U54 HL081007)
- (Baylor College of Medicine) (AP20187)
This publication has 43 references indexed in Scilit:
- Immunomodulatory properties of mesenchymal stromal cellsBlood, 2007
- Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytesBlood, 2007
- Potential risks of bone marrow cell transplantation into infarcted heartsBlood, 2007
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingThe International Journal of Cell Cloning, 2007
- Inducible Caspase 9 Suicide Gene to Improve the Safety of Allodepleted T Cells after Haploidentical Stem Cell TransplantationTransplantation and Cellular Therapy, 2007
- Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/ scid miceProceedings of the National Academy of Sciences, 2006
- Proarrhythmic Potential of Mesenchymal Stem Cell Transplantation Revealed in an In Vitro Coculture ModelCirculation, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Functional analysis of Fas signaling in vivo using synthetic inducers of dimerizationCurrent Biology, 1996
- Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 GeneHuman Gene Therapy, 1994